LAMEA Oncology Market: rising investment for treatment methods for thyroid cancer by 2021

2024-04-23 01:47:29 Industry

1285

The Oncology or anti - cancer drugs are the drugs that are often used for the treatment of the cancer patients. Some of the common cancers that are rampant currently are prostate cancer, ovarian cancer, testicular cancer, adenocarcinoma, pancreatic cancer, colon cancer etc. The LAMEA Oncology/Anti-cancer Drugs Market deals with the production, supply and distribution along with scope and demand in the LAMEA region during 2014-2021.

Check Complete Report @ http://www.marketintelreports.com/report/allied0103/lamea-oncologyanticancer-drugs-market--opportunities-and-forecasts-2014--2021

Topics Covered in this report:

Scope of the LAMEA Oncology/Anti-cancer Drugs Market:

The LAMEA Oncology/Anti-cancer Drugs Market is expected to reach $17,072.2 million by 2021. The rising cases of cancer, increasing investment by the government for research and development, capital expenditure by drug companies to develop drugs are the major factors driving this market during 2014-2021.

Anti - cancer drugs patent expiration of Herceptin (Patent Expiration: EU-2014; US-2019), Erbitux (Patent Expiration: EU-2014; US-2016), Rituxan (Patent Expiration: EU-2013; US-2018) and Avastin (Patent Expiration: EU-2018; US-2019) is expected to boost the production and supply growth of the LAMEA Oncology/Anti-cancer Drugs Market in LAMEA.

In the LAMEA Oncology/Anti-cancer Drugs Market, the biological therapy is expected to grow at a CAGR of 12.2% by 2021, whereas the blood cancer drugs are the largest segment to generate revenues during 2015. Brazil dominated this market with high investment and sales, closely followed by Argentina. LAMEA is poised to grow at a CAGR of 8.6% in this market during 2014-2021.

Segmentation and Key Players of the LAMEA Oncology/Anti-cancer Drugs Market:

The LAMEA Oncology/Anti-cancer Drugs Market is segmented into various categories by therapeutic modalities, by cancer type and by country as follows:

By therapeutic modalities: Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and others

By cancer type: Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Respiratory/Lung Cancer, Skin Cancer and other Cancers

By country: Brazil, Argentina, Nigeria, South Africa, Iraq, Iran, Algeria, Saudi Arabia and Egypt

Avail more information from Sample Brochure of report @ http://www.marketintelreports.com/pdfdownload.php?id=allied0103

The key players in the LAMEA Oncology/Anti-cancer Drugs Market are as follows:
? AstraZeneca Plc.
? Roche Diagnostics
? Sanofi
? Novartis
? GlaxoSmithKline PLC

The LAMEA Oncology/Anti-cancer Drugs Market is a rapidly growing market due to increasing cases of various cancer types in the population of the LAMEA region. This market is expected to witness high growth owing to increasing R&D investment by medical corporations, growing cases of cancer such as liver cancer, thyroid cancer, stomach cancer, bone cancer and others, affordability of cancer drugs and many others in the LAMEA region during 2014-2021.

Order a copy of LAMEA Oncology/Anti-cancer drugs Market - Opportunities and Forecasts, 2014 - 2021 Research Report@ http://www.marketintelreports.com/purchase.php?id=allied0103

About us:
MarketIntelReports (MIR) aim to empower our clients to successfully manage and outperform in their business decisions, we do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

A group of industry veterans who are well experienced in reputed international consulting firms after identifying the sourcing needs of MNCs for market intelligence, have together started this business savior MarketIntelReports.

MIR intends to be a one-stop shop with an intuitive design, exhaustive database, expert assistance, secure cart checkout and data privacy integrated. It curates the list of reports, publishers and studies to ensure that the database is constantly updated to dynamically meet the targeted, specific needs of our clients.

MarketIntelReports currently has more than 10,000 plus titles and 35+ publishers on our platform and growing consistently to fill the ?Global Intelligence Demand ? Supply Gap?. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.

Contact Us:
Sales Manager
Mayur.S
2711 Centerville Road, Suite 400,
Wilmington,
Delaware,
19808,
United States
http://www.marketintelreports.com
Email Id: sales@marketintelreports.com
Telephone: 1-302-261-5343